These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8297214)

  • 41. Clozapine and negative symptoms.
    Wing YK
    Br J Psychiatry; 1993 Jul; 163():121. PubMed ID: 8353681
    [No Abstract]   [Full Text] [Related]  

  • 42. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ; Doller JC
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine and electroconvulsive therapy.
    Fink M
    Arch Gen Psychiatry; 1990 Mar; 47(3):290-1. PubMed ID: 1968331
    [No Abstract]   [Full Text] [Related]  

  • 45. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simple schizophrenia in an adolescent.
    Valentí M; Castro-Fornieles J; Lázaro ML; Sugrañes G; Baeza I
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):589-90. PubMed ID: 19877985
    [No Abstract]   [Full Text] [Related]  

  • 48. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
    Meltzer HY
    Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
    [No Abstract]   [Full Text] [Related]  

  • 50. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine concentrations and clinical response in schizophrenic patients.
    Owen JA; Delva NJ; Lawson JS
    Am J Psychiatry; 1992 Aug; 149(8):1120-1. PubMed ID: 1636820
    [No Abstract]   [Full Text] [Related]  

  • 52. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
    Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine for the treatment of adolescents with schizophrenia.
    Birmaher B; Baker R; Kapur S; Quintana H; Ganguli R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):160-4. PubMed ID: 1537770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.
    Revicki DA; Luce BR; Weschler JM; Brown RE; Adler MA
    Hosp Community Psychiatry; 1990 Aug; 41(8):850-4. PubMed ID: 2169457
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia.
    Lee HS; Kwon KY; Alphs LD; Meltzer HY
    J Clin Psychopharmacol; 1991 Jun; 11(3):222-3. PubMed ID: 2066464
    [No Abstract]   [Full Text] [Related]  

  • 56. Risperidone response after no clozapine response.
    Avnon M; Kunin A
    Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340
    [No Abstract]   [Full Text] [Related]  

  • 57. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 58. Clozapine in refractory schizophrenia. Preliminary findings.
    Herrera JM; Costa J; Sramek J; Heh C
    Schizophr Res; 1988; 1(4):305-6. PubMed ID: 3154518
    [No Abstract]   [Full Text] [Related]  

  • 59. Differential effect of clozapine on weight: a controlled study.
    Bustillo JR; Buchanan RW; Irish D; Breier A
    Am J Psychiatry; 1996 Jun; 153(6):817-9. PubMed ID: 8633697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia.
    Zahn TP; Pickar D; Haier RJ
    Schizophr Res; 1994 Sep; 13(2):133-44. PubMed ID: 7986770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.